Known or suspected gram-negative infections, anaerobic infections, or fungemia
Known or suspected infections that are severe, life threatening or are not included in the ABSSSI Food and Drug Administration (FDA) guidance
Injection drug users with a fever
Severe neurological disorder leading to immobility or confined to a wheelchair
Bilateral Lower extremity involvement of the suspected infection.

NCT02961764_exc_T1
Qualifier
gram-negative
NCT02961764_exc_T2
Condition
infections
NCT02961764_exc_T3
Condition
infections
NCT02961764_exc_T4
Qualifier
anaerobic
NCT02961764_exc_T5
Condition
fungemia
NCT02961764_exc_T6
Condition
infections
NCT02961764_exc_T7
Qualifier
severe
NCT02961764_exc_T8
Qualifier
life threatening
NCT02961764_exc_T9
Person
drug users
NCT02961764_exc_T10
Condition
fever
NCT02961764_exc_T11
Condition
neurological disorder
NCT02961764_exc_T12
Qualifier
Severe
NCT02961764_exc_T13
Observation
immobility
NCT02961764_exc_T14
Device
wheelchair
NCT02961764_exc_T15
Scope
immobility or confined to a wheelchair
NCT02961764_exc_T16
Condition
infection
NCT02961764_exc_T17
Qualifier
Bilateral Lower extremity